secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0001683168-23-000098
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio Pharmaceuticals stockholders approve reverse stock split; ratio up to 1:25
-------------------------------------------------------------------------------

- Stockholders approved reverse stock split at ratio between 1:2 and 1:25; board to set exact ratio and effective date.
- Vote results: 19,728,800 For, 4,120,599 Against, 150,982 Abstain.
- Special meeting held January 4, 2023; record date November 17, 2022.
- Company also posted updated investor presentation on its website on January 6, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316823000098/0001683168-23-000098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316823000098/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-000098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer